Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors

<p>Glioblastoma patient characteristics (DFCI)</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: Joseph Toker (15399882) (author)
Diğer Yazarlar: J. Bryan Iorgulescu (15030477) (author), Alexander L. Ling (15399885) (author), Genaro R. Villa (15399888) (author), Josephina A.M.A. Gadet (15399891) (author), Laxmi Parida (15112564) (author), Gad Getz (14945542) (author), Catherine J. Wu (14944480) (author), David A. Reardon (15043854) (author), E. Antonio Chiocca (15399894) (author), Marco Mineo (15399897) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Biomarkers
CNS Cancers
Gliomas, Glioblastomas
Immunotherapy
Checkpoint blockade
Skin Cancers
Melanoma
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
Diğer Bilgiler
Özet:<p>Glioblastoma patient characteristics (DFCI)</p>

Benzer Materyaller